# Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)

> **NCT00019955** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Kidney Cancer

## Interventions

- **PROCEDURE:** laparoscopic surgery
- **PROCEDURE:** radiofrequency ablation
- **PROCEDURE:** thermal ablation therapy

## Key facts

- **NCT ID:** NCT00019955
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019955, "Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00019955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*